Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer
- DOI
- 10.1200/po-24-00500
- Published
- 2025-04
- Container
- JCO Precision Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/po-24-00500,
title = {Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer},
author = {Marcia S. Brose and C. Benedikt Westphalen and Xiaoyun Pan and Vadim Bernard-Gauthier and Milena Kurtinecz and Helen Guo and Virginie Aris and Neil R. Brett and Abdelali Majdi and Vivek Subbiah and Nathan A. Pennell and Kenneth L. Kehl and Alexander Drilon},
year = {2025},
journal = {JCO Precision Oncology},
doi = {10.1200/po-24-00500},
url = {https://doi.org/10.1200/po-24-00500}
}RIS
TY - JOUR TI - Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer AU - Marcia S. Brose AU - C. Benedikt Westphalen AU - Xiaoyun Pan AU - Vadim Bernard-Gauthier AU - Milena Kurtinecz AU - Helen Guo AU - Virginie Aris AU - Neil R. Brett AU - Abdelali Majdi AU - Vivek Subbiah AU - Nathan A. Pennell AU - Kenneth L. Kehl AU - Alexander Drilon PY - 2025 JO - JCO Precision Oncology DO - 10.1200/po-24-00500 UR - https://doi.org/10.1200/po-24-00500 ER -
APA
Brose, M. S., Westphalen, C. B., Pan, X., Bernard-Gauthier, V., Kurtinecz, M., Guo, H., Aris, V., Brett, N. R., Majdi, A., Subbiah, V., Pennell, N. A., Kehl, K. L., & Drilon, A. (2025). Larotrectinib Compared With Real-World Non–Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer. JCO Precision Oncology. https://doi.org/10.1200/po-24-00500
Source records
- crossref · retrieved 2026-09-26T20:51:39.208Z